The Valley Desk

NCT01399619 · Interventional trial

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Overall registry status Completed

Phase 3

Conditions Hepatitis C, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov